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735 Historical perspectives of The American Association for Thoracic Surgery:
Evarts A. Graham (1883–1957)AThomas A. D’Amico, MD, Durham, NCGeneral Thoracic
Surgery (GTS)
740 Initial consecutive experience of completely portal robotic pulmonary resection
with 4 arms
Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MD, MSPH, Loki Skylizard, MD, and
Douglas James Minnich, MD, FACS, Birmingham, AlaCH
DMany thoracic surgeons are learning robotic techniques for pulmonary resection. New technical
maneuvers can speed up the operation and shorten the learning curve. Completely portal robotic
lobectomy with 4 arms (CPRL-4) is safe and yields an R0 resection with complete removal of all
visible N2 and appropriate N1 lymph nodes.747 Prevalence, outcomes, and a risk–benefit analysis of diaphragmatic
hernia admissions: An examination of the National Inpatient Sample
database
Subroto Paul, MD, Farooq M. Mirza, MD, Abu Nasar, MS, Jeffrey L. Port, MD, Paul C. Lee, MD,
Brendon M. Stiles, MD, Andrew B. Nguyen, MD, Art Sedrakyan, MD, PhD, and
Nasser K. Altorki, MD, New York, NYTXAnalysis of the National Inpatient Sample demonstrates elective diaphragmatic hernia repair to be
associated with better outcomes than admissions for obstruction or gangrene with a favorable
risk–benefit profile than observation if the operative mortality is low.755 Ambulatory veno-venous extracorporeal membrane oxygenation: Innovation
and pitfalls
Jose P. Garcia, MD, Zachary N. Kon, MD, Charles Evans, MD, Zhongjun Wu, PhD,
Aldo T. Iacono, MD, Brian McCormick, CPP, and Bartley P. Griffith, MD,
Baltimore, Md/B
SETAlthough conventional ECMO has been shown to be beneficial in select patient populations,
advances in its application may further broaden its use. We present our early experience with an
ECMO treatment strategy, emphasizing rehabilitation and minimal mechanical ventilatory support,
with a goal of ambulation.)
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S714A The Journal of Thoracic an62 Compensation of pulmonary function after upper lobectomy versus lower
lobectomy(continued on page 16A
d Cardiovascular Surgery c October 2011Kazuhiro Ueda, MD, Toshiki Tanaka, MD, Masataro Hayashi, MD, Tao-Sheng Li, MD,
Takehiro Kaneoka, Nobuyuki Tanaka, MD, and Kimikazu Hamano, MD, Ube, Yamaguchi, JapanAlthough the lower lobectomy implies greater resection than the upper lobectomy, lung function
after lower lobectomy was not inferior to that after upper lobectomy because the compensatory
response appeared more robust after lower lobectomy.Acquired Cardiovascular
Disease (ACD)
768 Clinical and hemodynamic outcomes of ‘‘all-comers’’ undergoing transapical
aortic valve implantation: Results from the Italian Registry of Trans-Apical
Aortic Valve Implantation (I-TA)
Augusto D’Onofrio, MD, Paolo Rubino, MD, Melissa Fusari, MD, Loris Salvador, MD,
Francesco Musumeci, MD, Mauro Rinaldi, MD, Ettore O. Vitali, MD, Mattia Glauber, MD,
Roberto Di Bartolomeo, MD, Ottavio R. Alfieri, MD, Elvio Polesel, MD, Marco Aiello, MD,
Riccardo Casabona, MD, Ugolino Livi, MD, Claudio Grossi, MD, Mauro Cassese, MD,
Aniello Pappalardo, MD, Tiziano Gherli, MD, Guglielmo Stefanelli, MD,
Giuseppe G. Faggian, MD, and Gino Gerosa, MD, Padova, Mercogliano, Milan, Vicenza, Rome,
Turin, Bergamo, Massa, Bologna, Venice-Mestre, Pavia, Udine, Cuneo, Catanzaro, Trieste, Parma,
Modena, and Verona, ItalyFrom April 2008 until September 2010, 504 patients were enrolled in the Italian Registry of Trans-
Apical Aortic Valve Implantation (I-TA). Hospital mortality was 8.3%, and overall 2-year survival
was 71.5%6 6.2%. Transapical aortic valve implantation represents a safe and effective alternative
treatment for patients who are inoperable or at high risk for surgery.776 Aortic valve surgery: Marked increases in volume and significant decreases in
mechanical valve use—an analysis of 41,227 patients over 5 years from the
Society for Cardiothoracic Surgery in Great Britain and Ireland National
database
Joel Dunning, PhD, Haiyan Gao, PhD, John Chambers, MD, FRCP, Neil Moat, MS, FRCS,
Gavin Murphy, MD, Domenic Pagano, MD, FRCS(CTh), Simon Ray, MD, FRCP,
James Roxburgh, MS, FRCS(CTh), and Ben Bridgewater, PhD, FRCS(CTh), Middlesbrough,
London, Bristol, Birmingham, and Manchester, United KingdomWe analyzed all 41,227 patients undergoing AVR in the United Kingdom national cardiac database
from 2004 to 2009.We found significant increases in mean age (68.8-70.2 years), proportion of
patients with aortic stenosis (62.4%-65.1%), octogenarians(13.6%-18.4%), high-risk patients
(24.6%-27.7%), and those receiving biologic valves (65.4%-77.8%). Mortality decreased from
4.4% to 3.7%. The 2.5-year survival was 89%.783 Pulmonary hypertension predicts adverse cardiac events after restrictive
mitral annuloplasty for severe functional mitral regurgitation
Satoshi Kainuma, MD, Kazuhiro Taniguchi, MD, PhD, Koichi Toda, MD, PhD,
Toshihiro Funatsu, MD, PhD, Haruhiko Kondoh, MD, PhD, Masami Nishino, MD, PhD,
Takashi Daimon, PhD, and Yoshiki Sawa, MD, PhD, Osaka and Hyogo, JapanWe investigated the prognostic role of pulmonary hypertension in patients undergoing restrictive
mitral annuloplasty for severe functional mitral regurgitation and found that pulmonary
hypertension is an excellent prognostic tool for such patients. In particular, severe pulmonary
hypertension (systolic pulmonary artery pressure . 60 mm Hg) was shown to be a predictor of
adverse cardiac events and cardiac remodeling.)
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d Cardiovascular Surgery c October 2011Joon Bum Kim, MD, Joon-Won Kang, MD, Hyun Song, MD, Sung Ho Jung, MD,
Suk Jung Choo, MD, Cheol Hyun Chung, MD, Jae Won Lee, MD, and Tae-Hwan Lim, MD,
Seoul, South KoreaA large proportion of bypassed grafts initially showing poor patency after coronary artery bypass
grafting demonstrated patency restoration on serial coronary multidetector computed tomographic
angiography. Radial artery use, larger target coronary artery size, and target vessel stenosis of at
least 90% were significant correlative factors.800 Prognostic implications of pulmonary hypertension in patients with severe
aortic stenosis
Akin Cam, MD, Sachin S. Goel, MD, Shikhar Agarwal, MD, MPH, Venu Menon, MD,
Lars G. Svensson, MD, PhD, E. Murat Tuzcu, MD, and Samir R. Kapadia, MD,
Cleveland, OhioThe prognosis of patients with severe aortic stenosis and pulmonary hypertension who did not
undergo aortic valve replacement is poor. The benefits of the surgery may outweigh the risk of
surgery, with survival comparable to that of patients with nonsevere pulmonary hypertension.
Aortic valve replacement should seriously be considered for these patients.809 Branch-first aortic arch replacement with no circulatory arrest or deep
hypothermia
George Matalanis, MBMS, FRACS, Rhiannon S. Koirala, MBBS, William Y. Shi, MBBS,
Philip A. Hayward, BMBCh, FRCS, and Peter R. McCall, MBBS, FANZCA, Melbourne,
AustraliaThe potential risks of conventional aortic arch surgery have been widely documented. We describe
a novel ‘‘branch-first continuous perfusion’’ technique that avoids both deep hypothermia and
circulatory arrest. This brings us closer to the goal of arch surgery without cerebral or visceral
ischemia and the morbidity of deep hypothermia.816 Changing trends in emergency coronary bypass surgery
Manjula Maganti, MSc, Stephanie J. Brister, MD, Terrence M. Yau, MSc, MD,
Susan Collins, Mitesh Badiwala, MD, and Vivek Rao, MD, PhD, Toronto,
Ontario, CanadaA retrospective review of patients undergoing emergency CABG over the past 20 years was
conducted. Operative mortality is 8.1% and is significantly above the observed mortality in elective
CABG. Continued improvements in the management of heart failure will likely result in reduced
risks of emergency CABG.823 Surgical treatment of intracardiac leiomyomatosis
Hui-Li Gan, MD, PhD, Jian-Qun Zhang, MD, Qi-Wen Zhou, MD, Qing-Yu Kong, MD,
Shuang Zhao, MD, and Ping Bo, MD, Beijing, ChinaThis report outlines surgical management and outcomes of 16 patients with intracardiac
leiomyomatosis reviewed retrospectively. Surgical excision remains an effective therapy for
treating patients with benign metastasizing leiomyomatosis. Recurrence of intracardiac
leiomyomatosis after the resection procedure may carry an unfavorable late result.)
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d Cardiovascular Surgery c October 2011Mark A. Hlatky, MD, David Shilane, PhD, Derek B. Boothroyd, PhD, Eric Boersma, PhD,
Maria M. Brooks, PhD, Didier Carrie, MD, PhD, Tim C. Clayton, MSc, Nicolas Danchin, MD,
Marcus Flather, MBBS, FRCP, Christian W. Hamm, MD, Whady A. Hueb, MD,
Jan Kahler, MD, Neuza Lopes, MD, Stuart J. Pocock, PhD, Alfredo Rodriguez, MD, PhD,
Patrick Serruys, MD, Ulrich Sigwart, MD, and Rodney H. Stables, MD, Stanford, Calif; Rotterdam,
The Netherlands; Pittsburgh, Pa; Toulouse and Paris, France; London and Liverpool,
United Kingdom; Bad Nauheim and Hereford, Germany; S~ao Paulo, Brazil; Buenos Aires,
Argentina; and Geneva, SwitzerlandAmong 3087 patients followed for a median of 6.7 years, patients who received an internal thoracic
artery graft during coronary bypass surgery had lower mortality than patients who received only
vein grafts (hazard ratio, 0.77). They also had fewer myocardial infarctions (hazard ratio, 0.83),
repeat procedures (hazard ratio, 0.82), and cases of angina (hazard ratio, 0.81).836 Impact of early surgery in the active phase on long-term outcomes in left-sided
native valve infective endocarditis
Shunsuke Funakoshi, MD, Shuichiro Kaji, MD, Atsushi Yamamuro, MD,
Tomoko Tani, MD, Makoto Kinoshita, MD, Yukikatsu Okada, MD, and
Yutaka Furukawa, MD, Kobe, JapanThe freedom rates from infective endocarditis-related death andMACEwere significantly higher in
patients who underwent operation within 2 weeks after the initial diagnosis than in patients who
received the conventional treatment strategy. Early surgery in the active phase was associated with
better long-term outcomes in patients with left-sided infective endocarditis.843 Early and midterm results of totally endoscopic coronary artery bypass
grafting on the beating heart
Changqing Gao, MD, Ming Yang, MD, Yang Wu, MD, Gang Wang, MD, Cangsong Xiao, MD,
Yue Zhao, RN, and Jiali Wang, BS, Beijing, ChinaWe performed totally endoscopic coronary artery bypass grafting on the beating heart in 60
patients, and the clinical results and patency of anastomosis were excellent.Congenital Heart
Disease (CHD)
850 Totally thoracoscopic repair of ventricular septal defect: A short-term clinical
observation on safety and feasibility
Zeng-Shan Ma, MD, Ming-Feng Dong, MD, Qiu-Yang Yin, MD, Zhi-Yu Feng, MD, and
Le-Xin Wang, MD, PhD, Liaocheng, China, and Wagga Wagga, AustraliaThoracoscopic repair was performed in 36 patients with perimembranous ventricular septal
defects (VSDs; age, 5–19 years). Through 3 port incisions in the right chest, pericardiotomy,
bicaval occlusion, atriotomy, and VSD repair were performed by a surgeon by means of
thoracoscopy. There were no mortalities and no major complications. Transesophageal
echocardiographic analysis after the operation showed complete closure of the defect without
residual shunt. The intensive care or hospital stays in the last 16 thoracoscopic group patients
was shorter than in the 16 control group patients. The percentage of patients that required
postoperative opioid analgesics in the thoracoscopic group was lower than in the control group.
We conclude that totally thoracoscopic repair is feasible and safe in older patients with
perimembranous VSDs.)
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d Cardiovascular Surgery c October 2011Nancy C. Dobrolet, MD, Jo Ann Nieves, MSN, CPN, ARNP, PNP-BC, Elizabeth M. Welch, MD,
Danyal Khan, MD, Anthony F. Rossi, MD, Redmond P. Burke, MD, and Evan M. Zahn, MD,
Miami, FlaThis study describes the initiation of a high-risk program to decrease interstage mortality and to
provide early detection of residual/recurrent lesions in palliated neonatal patients with congenital
heart disease.861 Modified versus conventional ultrafiltration in pediatric cardiac surgery:
A meta-analysis of randomized controlled trials comparing clinical outcome
parameters
Norifumi Kuratani, MD, PhD, Piyaporn Bunsangjaroen, MD, Thanaphon Srimueang, MD,
Eiji Masaki, MD, PhD, Takaaki Suzuki, MD, PhD, and Toshiyuki Katogi, MD, PhD, Tochigi,
Miyagi, and Saitama, Japan; and Khon Khan, ThailandA meta-analysis of randomized controlled trials was performed to clarify the clinical benefit of
modified versus conventional ultrafiltration in pediatric cardiac surgery. The results revealed that
modified ultrafiltration improved immediate postbypass condition, whereas postoperative clinical
outcome parameters were unchanged.868 Repair of anomalous origin of the left coronary artery from the pulmonary
artery in infants and children
Vladimir Alexi-Meskishvili, MD, PhD, Boris A. Nasseri, MD, Sarah Nordmeyer, MD,
Boris Schmitt, MD, Yu-Guo Weng, MD, Wolfgang B€ottcher, ECCP, Michael H€ubler, MD,
Felix Berger, MD, PhD, and Roland Hetzer, MD, PhD, Berlin, GermanyTwenty-seven pediatric patients with anomalous origin of left coronary artery from the pulmonary
artery underwent direct aortic reimplantation without deaths. Despite normalization of global left
ventricular function and open coronary anastomosis, scars and left ventricular myocardial
perfusion abnormalities were noted during magnetic resonance imaging follow-up. These patients
need lifelong surveillance.875 Minimizing intraoperative hemodilution by use of a very low priming volume
cardiopulmonary bypass in neonates with transposition of the great arteries
Matthias Redlin, MD, Michael Huebler, MD, Wolfgang Boettcher, ECCP,
Marian Kukucka, MD, Helge Schoenfeld, MD, Roland Hetzer, MD, PhD, and
Helmut Habazettl, MD, PhD, Berlin, GermanyA very low-volume (95-110 mL) cardiopulmonary bypass circuit allowed for transfusion-free
arterial switch operation in 17 of 23 of neonates. Preoperative hemoglobin concentration predicted
the need for intraoperative transfusion. Regional tissue oxygenation and in-hospital patient
outcome were not different among infants with or without blood transfusion.882 Impact of prior hospital mortality versus surgical volume on mortality
following surgery for congenital heart disease
Matthew E. Oster, MD, Matthew J. Strickland, PhD, and William T. Mahle, MD, Atlanta, GaUsing the Pediatric Health Information Systems database, we compared the effects of prior in-
hospital mortality and surgical volume on future mortality after surgery in pediatric patients with
congenital heart disease. Prior in-hospital postoperative mortality was significantly associated with
future in-hospital mortality across all risk strata; hospital surgical volume tended to be significant
only for higher-risk operations.)
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887 Pretreatment strategy with adenosine A2A receptor agonist attenuates
reperfusion injury in a preclinical porcine lung transplantation
model(continued on page 24A
The Journal of Thoracic and Cardiovascular Surgery c Volume 142, Number 4 21AEDDamien J. LaPar, MD, MSc, Victor E. Laubach, PhD, Abbas Emaminia, MD,
Ivan K. Crosby, MD, Vanessa A. Hajzus, BS, Ashish K. Sharma, MBBS, Heather M. Sumner, MD,
David V. Webb, MD, Christine L. Lau, MD, and Irving L. Kron, MD, Charlottesville, VaS
G
TThis study compares the efficacy of 3 strategies for A2AR agonist treatment for reperfusion injury
after porcine lung transplantation: pretreatment of donor lungs, treatment after transplantation, and
a combination of both. Pretreatment of donor lungs with a single bolus of A2AR agonist protects
against reperfusion injury.Evolving Technology/
Basic Science (ET/BS)
895 Increased macrophage infiltration and neovascularization in congenital
bicuspid aortic valve stenosisA
CDPedro R. Moreno, MD, Luis Astudillo, MD, Sammy Elmariah, MD, MPH,
K. Raman Purushothaman, MD, Meeranani Purushothaman, PhD, Patrick A. Lento, MD,
Samin K. Sharma, MD, Valentin Fuster, MD, PhD, and David H. Adams, MD, New York, NY,
Boston, Mass, and Madrid, SpainPatients with congenital bicuspid aortic valves (CBAVs) have aortic stenosis (AS) at a relatively
young age compared with patients with tricuspid aortic valves. We demonstrate that AS in patients
with CBAVs is associated with increased inflammatory cell infiltration and neovascularization.
These findings might explain the rapid progression of AS in patients with CBAVs.9D02 Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1
predict brain injury in a canine model of hypothermic circulatory arrestHCGeorge J. Arnaoutakis, MD, Timothy J. George, MD, Kevin K. Wang, PhD,
Mary Ann Wilson, PhD, Jeremiah G. Allen, MD, Chase W. Robinson, MHS,
Kara A. Haggerty, BS, Eric S. Weiss, MD, MPH, Mary E. Blue, PhD,
Charles C. Talbot, Jr, BA, Juan C. Troncoso, MD, Michael V. Johnston, MD, and
William A. Baumgartner, MD, Baltimore, Md, and Alachua, FlaThis study examined the ability of a novel neuron-specific biomarker to detect brain injury in
a canine model of CPB and HCA. Increasing serum levels of UCHL1 at 8 hours in animals
subjected to 2h-HCA were associated with impaired function and histologic neurologic
damage.TX
911 Intramyocardial bone marrow stem cell transplantation during coronary
artery bypass surgery: A meta-analysis
Peter Donndorf, MD, Guenther Kundt, PhD, Alexander Kaminski, MD,
Can Yerebakan, MD, Andreas Liebold, MD, PhD, Gustav Steinhoff, MD, PhD, and
Aenne Glass, Rostock, GermanyET
/B
SWe have conducted a systematic review and meta-analysis of available publications regarding the
efficacy and safety of intramyocardial bone marrow stem cell transplantation during coronary
artery bypass grafting. Six studies were included. Available clinical evidence suggests that
intramyocardial bone marrow stem cell transplantation in combination with coronary artery
bypass grafting can be performed safely and is associated with improvements of functional
parameters.)
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d Cardiovascular Surgery c October 2011Mark S. Slaughter, MD, Brian Pederson, BS, Joel D. Graham, MS, Michael A. Sobieski, RN, CCP,
and Steven C. Koenig, PhD, Louisville, Ky, and Minneapolis, MinnForcefield (ATS Medical, Inc, Minneapolis, Minn) is a novel technique that increases
thromboresistance of pyrolytic carbon by attracting inherently charged blood components. This
procedure may reduce or prevent surface platelet adhesion and activation seen with implanted
pyrolytic carbon medical devices, thereby alleviating the need for anticoagulation therapy.926 Ischemic postconditioning promotes left ventricular functional recovery after
cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion
injury on cardiopulmonary bypass
Gen Shinohara, MD, Kiyozo Morita, MD, PhD, Ryuichi Nagahori, MD, PhD, Yoshihiro Koh, MD,
PhD, Katsushi Kinouchi, MD, Takayuki Abe, MD, and Kazuhiro Hashimoto, MD, PhD, Tokyo,
JapanPostconditioning after cardioplegic arrest under CPB was examined in piglets. Postconditioning of
6 cycles of unclamping and reclamping of 10 seconds each limited troponin-T release, improved
Ees, and improved Tau (P , .05), whereas postconditioning of 3 cycles of 30 seconds each
improved Ees, Tau (P , .01), and LVSWI (P , .05). Both protocols similarly limited myocardial
lipid peroxide (P , .05).933 Technique for aortic valve annuloplasty using an intra-annular
‘‘hemispherical’’ frame
J. Scott Rankin, MD, L. Alan Beavan, MSE, and William E. Cohn, MD, Nashville, Tenn; and Austin
and Houston, TexOn the basis of a hemispherical model of aortic valve and root geometry, a 3-dimensional aortic
valve annuloplasty frame has been developed to reestablish normal aortic root geometry. Testing in
isolated and intact animal models suggests efficacy of the device and supports continued prototype
development for aortic valve repair.Cardiothoracic
Imaging
937 Aneurysmal right coronary with fistula to the coronary sinus combined with
severe stenosis of the left anterior descending artery: A snake on the heart
Lei Yu, MD, Enyi Shi, MD, PhD, and Tianxiang Gu, MD, PhD, Shenyang, People’s Republic of
China940 Large left ventricular aneurysm
Antonio Grimaldi, MD, Alessandro Castiglioni, MD, Michele De Bonis, MD, and Ottavio Alfieri,
FECTS, Milan, ItalyBrief Technique Reports 942 Videothoracoscopic repair of pectus excavatum with sternal transection for
adult patients with nonelastic deformity
David Perez, MD, PhD, Jose R. Cano, MD, Santiago Quevedo, MD, PhD, and Luis Lopez, MD,
PhD, Las Palmas de Gran Canaria, Spain944 Awake single-access (uniportal) video-assisted thoracoscopic surgery for
spontaneous pneumothorax
Gaetano Rocco, MD, FRCSEd, Antonello La Rocca, MD, Nicola Martucci, MD, and Rosanna
Accardo, MD, Naples, Italy)
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from the sternum through the left hemithorax in redo coronary artery surgery:
A new approach(continued on page 28A
d Cardiovascular Surgery c October 2011Tomonobu Abe, MD, Tetsuo Taniguchi, MD, Takafumi Terada, MD, and Hajime Sakurai, MD,
Nagoya, Japan948 Secure anastomosis for damaged aortic root reconstruction: Graft insertion
technique
Yoshitsugu Nakamura, MD, Osamu Tagusari, MD, Junjiro Kobayashi, MD, and
Hiroyuki Nakajima, MD, Tokyo and Osaka, Japan950 How to choose the best available homograft to reconstruct the right ventricular
outflow tract
David Kalfa, MD, Lo€ıc Mace, MD, Dominique Metras, MD, and Bernard Kreitmann, MD,
Marseille, FranceLetters to the Editor 954 Peroxisome proliferator g coactivator 1 and mitochondrial function in
hibernating myocardium
Luca Siracusano, MD, and Viviana Girasole, MD, Messina, Italy954 Reply to the Editor
Rosemary F. Kelly, MD, Jesus A. Cabrera, MD, PhD, and Edward O. McFalls, MD, PhD,
Minneapolis, Minn955 Management of acute esophageal necrosis
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